LAVA THERAPEUTICS NV LAVA Therapeutics N.V. operates as a biotechnology company. The Company develops proprietary T Cell engaging bispecific antibodies to treat cancer, as well as immune oncology biopharmaceutic delivering the primary targeted treatment in combination with immune recruiting and activating functionality. LAVA Therapeutics serves customers worldwide.